Li C, Stražar M, Mohamed AMT, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. 2024. doi:10.1016/j.cell.2024.03.014
Publications
Liu Z, Remsberg JR, Li H, et al. Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.3c13448
Thomas CE, Georgeson P, Qu C, et al. Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2024;33(4):534-546. doi:10.1158/1055-9965.EPI-23-0600
Merryman RW, Rhoades J, Xiong K, et al. Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma. HemaSphere. 2024;8(4):e47. doi:10.1002/hem3.47
Oh J, Lee M, Kim M, et al. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nature communications. 2024;15(1):2830. doi:10.1038/s41467-024-47176-w
Lemire G, Sanchis-Juan A, Russell K, et al. Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease. American journal of human genetics. 2024. doi:10.1016/j.ajhg.2024.03.008
Kelly DM, Pinheiro AA, Koini M, et al. Impaired Kidney Function, Cerebral Small Vessel Disease and Cognitive Disorders: The Framingham Heart Study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024. doi:10.1093/ndt/gfae079
Baharav TZ, Tse D, Salzman J. OASIS: An interpretable, finite-sample valid alternative to Pearson’s for scientific discovery. Proceedings of the National Academy of Sciences of the United States of America. 2024;121(15):e2304671121. doi:10.1073/pnas.2304671121
Pecci F, Nakazawa S, Ricciuti B, et al. Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors. Cancer discovery. 2024. doi:10.1158/2159-8290.CD-23-1217
Sun C, Zhou C, Daneshvar K, et al. Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in hepatic stellate cells. Hepatology (Baltimore, Md.). 2024. doi:10.1097/HEP.0000000000000822